SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Tag: EYLEA

    Summary of Research and Developments in Macular Degeneration, 2012-2013

    Posted on June 1, 2013 by droberts
  • June 1, 2013

    Summary of Research and Developments in Macular Degeneration, 2012-2013

    by Dan Roberts June 2013 INTRODUCTION This is a summary of reports about significant research and development in the field of macular degeneration and related diseases presented since June 2012 and May 2013. I will briefly describe the conclusions of 77 studies that have been presented in the areas of therapy, prevention, technology, nutrition and […]

      Also posted in
    • Research and Developments
  • Antiangiogenic Drugs Are Stopping Neovascularization in Wet Macular Degeneration

    Posted on September 27, 2012April 5, 2022 by droberts
  • September 27, 2012

    Antiangiogenic Drugs Are Stopping Neovascularization in Wet Macular Degeneration

    (Updated 3/12/22) A substance in the body called Vascular Endothelial Growth Factor (VEGF) is responsible for the growth of new blood vessels. It promotes this growth by stimulating the endothelial cells, which form the walls of the vessels and transport nutrients and oxygen to the tissues. Evidence shows that when the retinal pigment epithelial (RPE) […]

      Also posted in
    • Research and Developments
  • Summary of Research and Developments in Macular Degeneration, 2011-2012

    Posted on June 1, 2012 by droberts
  • June 1, 2012

    Summary of Research and Developments in Macular Degeneration, 2011-2012

    by Dan Roberts June 2012 Introduction Here is MD Support’s summary of the the past twelve months of significant research and development in the field of macular degeneration. We begin with the field that has been making the most news: pharmacology. _______________________________ PHARMACOLOGY SEP: Infection Risk From Repackaged Avastin The big pharmaceutical news of the […]

      Also posted in
    • Research and Developments
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.